08/06/2025
6:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2025
6:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2025
7:25 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2025
3:12 PM | NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2025
3:25 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2025
6:41 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:42 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:50 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
11:31 AM | NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2025
8:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
6:28 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for NAMSW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. |
06/06/2025
3:35 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
3:40 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2025
10:44 AM | Capital World Investors (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SCHEDULE 13G | |
05/08/2025
3:28 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form ARS | |
05/08/2025
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025
6:36 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
4:41 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
4:34 PM | Gulfo Adele M. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
4:36 PM | Gulfo Adele M. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
4:41 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
4:06 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
4:36 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:18 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:20 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:24 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:29 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
5:19 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2025
5:00 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2025
3:27 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:29 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
11:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form EFFECT | |
03/10/2025
3:52 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B3 | |
03/06/2025
4:32 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:10 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:54 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:06 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/26/2025
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2025
4:24 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly. |
02/14/2025
5:42 PM | NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
4:00 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:25 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:16 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
4:09 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
3:52 PM | NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
Somaiya Mayur Ian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
3:26 PM | NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
7:27 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:58 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
van der Kamp Hilde Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:03 PM | Lewis William (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:08 PM | McKenna Mark C. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:09 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
4:57 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:08 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:10 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:12 PM | JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:29 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/06/2025
4:57 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:48 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:51 PM | JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:53 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:54 PM | Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:56 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:25 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:35 PM | BCLS II Investco, LP (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13D/A | |
12/17/2024
4:05 PM | Bain Capital Life Sciences Fund II, L.P. (Reporting)
Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors II, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
BCLS Fund III Investments GP, LLC (Reporting)
BCLS Fund III Investments, LP (Reporting)
BCLS II Investco , LLC (0001819101) (Reporting)
BCLS II Investco, LP (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:00 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13D/A | |
12/17/2024
9:28 AM | Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13D/A | |
12/16/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
7:28 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
5:33 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B5 | |
12/12/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:57 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form S-3MEF | |
12/10/2024
3:48 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B5 | |
12/10/2024
6:24 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
6:07 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
3:29 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13D/A | |
11/14/2024
4:46 PM | NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/06/2024
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2024
7:02 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 20-F/A | |
10/18/2024
3:51 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
4:01 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Coin That Could Define Trump’s Crypto Presidency (Ad) When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed.
While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.” Discover the coin that could define Trump’s crypto presidency. |
10/01/2024
4:23 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:12 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
4:22 PM | Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:20 PM | AMGEN INC (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13G/A | |
08/22/2024
3:30 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
11:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form EFFECT | |
08/09/2024
4:21 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B5 | |
08/09/2024
4:23 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
4:24 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form POS AM | |
